Physician profile
Ann Barela
NPI 1942759444
$664.15
in general payments reported to CMS, 2019-2025
14 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $383 · 2022: $81.33 · 2023: $52.79 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $199.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $124.90 | 2021 | |
| Medtronic, INC. | $121.27 | 2022-2023 | Interstim |
| Hollister Incorporated | $107.55 | 2025 | Premier, New Image |
| Lilly USA, LLC | $72.94 | 2021 | |
| Boston Scientific Corporation | $52.21 | 2023-2025 | Watchman Flx, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.96 | 2021 | |
| Glaxosmithkline, LLC. | $30.99 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $23.57 | 2021 | |
| Optos, INC. | $23.19 | 2021 | |
| Bausch Health US, LLC | $18.15 | 2021 | |
| Novo Nordisk INC | $15.89 | 2021 | |
| Amgen INC. | $14.26 | 2021 | |
| Vyera Pharmaceuticals, LLC | $12.81 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Barela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.